144 related articles for article (PubMed ID: 14609277)
1. Synthesis of benzylamides of dipeptides as potential inhibitors of plasmin.
Midura-Nowaczek K; Roszkowska-Jakimiec W; Lepietuszko I; Bruzgo I
Pharmazie; 2003 Oct; 58(10):687-9. PubMed ID: 14609277
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
Midura-Nowaczek K; Lepietuszko I; Bruzgo I
Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
[TBL] [Abstract][Full Text] [Related]
3. Peptide inhibitors of plasmin.
Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
Acta Pol Pharm; 1990; 47(1-2):39-42. PubMed ID: 12959258
[TBL] [Abstract][Full Text] [Related]
4. Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
Purwin M; Bruzgo I; Markowska A; Midura-Nowaczek K
Pharmazie; 2009 Nov; 64(11):765-7. PubMed ID: 20099524
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of amide derivatives of lysine.
Midura-Nowaczek K; Lepietuszko I; Bruzgo I; Markowska A
Acta Pol Pharm; 2008; 65(3):377-81. PubMed ID: 18646558
[TBL] [Abstract][Full Text] [Related]
6. Low molecular peptides as potential inhibitors of plasmin.
Markowska A; Midura-Nowaczek K; Bruzgo I
Acta Pol Pharm; 2007; 64(4):355-8. PubMed ID: 18536161
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of N-alpha-(arylsulfonyl)-4-amidino-phenylalanyl-prolines and N-alpha-(arylsulfonylglycyl)-4-amidino-phenylalanyl-prolines and testing of them as inhibitors of serine proteinases. 33. Synthetic inhibitors of serine proteinases].
Voigt B; Stürzebecher J; Wagner G; Markwardt F
Pharmazie; 1988 Jun; 43(6):412-4. PubMed ID: 2974999
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological inhibition of thrombin and plasmin activity].
Potetinova ZhV; Voiushina TL; Drozd NN; Makarov VA
Eksp Klin Farmakol; 2001; 64(5):72-8. PubMed ID: 11764510
[No Abstract] [Full Text] [Related]
10. Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions.
Sakamoto H; Shimohigashi Y; Maeda I; Nose T; Nakashima K; Nakamura I; Ogawa T; Kawano K; Ohno M
J Mol Recognit; 1993 Jun; 6(2):95-100. PubMed ID: 8305253
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity of amides of tripeptides as potential urokinase inhibitors.
Markowska A; Bruzgo I; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):139-42. PubMed ID: 20030517
[TBL] [Abstract][Full Text] [Related]
12. Design of serine protease inhibitors with conformation restricted by amino acid side-chain-side-chain CH/pie interaction.
Shimohigashi Y; Nose T; Yamauchi Y; Maeda I
Biopolymers; 1999; 51(1):9-17. PubMed ID: 10380349
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
Gilboa N; Villannueva GB; Fenton JW
Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
[TBL] [Abstract][Full Text] [Related]
14. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
15. Analgesic dipeptide derivatives. II. Synthetic dipeptides containing a C-terminal 2-(2-nitrophenylsulfenyl) tryptophan residue.
García-López MT; González-Muñiz R; Herranz R; Molinero MT; Del Rio J
Int J Pept Protein Res; 1987 May; 29(5):613-20. PubMed ID: 3610476
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of dipeptides containing S-hexylcysteine.
Bruzgo I; Midura-Nowaczek K
Acta Pol Pharm; 2007; 64(5):479-82. PubMed ID: 18540170
[No Abstract] [Full Text] [Related]
17. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
18. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
[TBL] [Abstract][Full Text] [Related]
19. Heterocyclic thrombin inhibitors. Part 1: design and synthesis of amidino-phenoxy quinoline derivatives.
Ries UJ; Priepke HW; Hauel NH; Haaksma EE; Stassen JM; Wienen W; Nar H
Bioorg Med Chem Lett; 2003 Jul; 13(14):2291-5. PubMed ID: 12824020
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and study of phytotoxicity of N-arylalkyl substituted amides. I. Benzylamides].
Borgna P; Vicarini L; Calderara G
Farmaco Sci; 1977 Nov; 32(11):813-26. PubMed ID: 923794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
